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Abstract
Background: In 1996, the U.S. Food and Drug Administration approved regulations authorizing an
exception from informed consent (EFIC) for research conducted in emergency settings when obtaining
prospective informed consent is not possible due to the potential subject’s critical illness or injury. The
regulations require that investigators conduct community consultation (CC) efforts before initiating a
study and require that institutional review boards review the results of CC prior to approving a study.
However, little is known about how communities view EFIC research or the CC process.
Objectives: The objective was to assess the views of CC meeting attendees regarding the CC process,
their understanding and views of EFIC research relating to the specific research trial under discussion,
and their level of trust in physician-investigators.
Methods: Following CC meetings at two study sites (San Francisco and Atlanta) for the Rapid
Anticonvulsant Medication Prior to Arrival Trial (RAMPART), an active comparison, randomized trial of
prehospital treatment for status epilepticus, the authors administered a pair of surveys to participants.
One survey focused on CC experiences (CC survey) and trust in physician-investigators; the second
assessed participants’ understanding of EFIC and the RAMPART clinical trial design (EFIC survey).
Results: A total of 317 individuals participated in one of the two most popular types of CC meetings
(group meetings and focus group sessions) at both sites. A total of 189 participants (59%) completed the
CC survey and trust questions, and 297 (92%) completed the EFIC survey. Of those who completed the
CC survey, 173 of 189 (92%) were very satisfied with the meeting, and 174 of 189 (92%) felt that they
learned a lot about research at the meeting. A total of 169 of 189 participants (88%) felt that researchers
heard the community’s concerns, while only 106 of 189 (56%) said researchers would be willing to make
changes to the study based on their concerns. Of those who completed the EFIC survey, 261 of 297
(88%) supported the study, 207 of 297 (70%) said they would agree to participate in the study, and 203 of
297 (68%) reported that they would agree to consent a loved one into the study. On a recently validated
scale measuring trust in physician-investigators, participants at both sites seemed to have higher levels
of trust in physician-investigators than the validation study population.
Conclusions: Overall, members of these two communities expressed satisfaction with the CC session and
had relatively high levels of support for the study and trust in physician-investigators.
ACADEMIC EMERGENCY MEDICINE 2013; 20:98–103 © 2013 by the Society for Academic Emergency
Medicine
From the Department of Emergency Medicine, University of California (PG, ND), San Francisco, CA; the Division of Cardiology,
Department of Medicine, Emory University (NWD), Atlanta, GA; the Department of Neurology, San Francisco General Hospital
(MM, CJH), San Francisco, CA; the Department of Emergency Medicine, University of Michigan (DH), Ann Arbor, MI, and Hema-
tology and Oncology in Ethics, Winship Cancer Institute (RP), Atlanta, GA.
Received February 14, 2012; revision received April 20, 2012; revision received and accepted April 29, 2012.
Presented at the National Association of EMS Physicians annual meeting, Phoenix, AZ; January 2010.
The primary author was funded by a career development award (1K08HS017965-01) from the Agency of Healthcare Research and
Quality and the American Heart Association/American Stroke Association Western States Clinical Research Program.
The authors have no potential conflicts of interest to disclose.
A related commentary appears on page 104.
Supervising Editor: James Adams, MD.
Address for correspondence and reprints: Prasanthi Govindarajan, MBBS, MAS; e-mail: prasanthi.ramanujam@emergency.ucsf.edu.
98 PII ISSN 1069-6563583 doi: 10.1111/acem.12039
ISSN 1069-6563 © 2013 by the Society for Academic Emergency Medicine
I nformed consent is an important ethical require-ment for most research involving human subjects.However, when conducting clinical research on
treatment for acute and life-threatening conditions, it is
often impractical or impossible to obtain prospective
consent from the patient or a surrogate. Under such cir-
cumstances, U.S. Food and Drug Administration and
Department of Health and Human Services regulations
allow an exception from the requirement for prospec-
tive informed consent (EFIC; 21 CFR 50.24).1 These reg-
ulations contain specific provisions regarding which
studies are eligible for EFIC. They also require that
investigators consult with members of the community in
which the research will be conducted. The EFIC regula-
tions define community consultation (CC) as consulta-
tion with representatives of the communities in which
the clinical investigation will be conducted (geographic
community) and from which the subjects will be drawn,
i.e., population of potential research subjects, which is
the condition-oriented community.2 However, the pub-
lished guidelines on how CC should be conducted, or
how input received from CC ought to be incorporated
into study design or review,2 are vague.
Various methods of CC have been implemented by
research teams conducting EFIC research. For example,
open public forums, meetings with existing community
groups, focus groups, and face-to-face and telephone
surveys are all commonly employed. These methods dif-
fer greatly in size, scope, expense, and level of interac-
tion with participants, and they likely accomplish
different potential goals of CC. There remains a need to
clarify the various goals of the CC process in EFIC
research, develop outcome measures for those goals,
and use those measures to assess the effectiveness of
particular methods and identify best practices. Assessing
the views of community members on the CC process is
an important step in achieving these goals.3
In this study, our objectives were to assess the atti-
tudes of CC participants toward the process of CC and
EFIC. We also sought to ascertain their level of trust in
medical researchers, both because promoting trust is
often described as one goal of CC3 and because it is
unknown whether CC participants tend to reflect the
general population regarding their general attitudes
toward research and researchers.
METHODS
Study Design and Population
This was a survey study to assess participant responses to
CC on EFIC. The study was conducted within the Rapid
Anticonvulsant Medication Prior to Arrival Trial (RAM-
PART), a study conducted through the Neurological Emer-
gencies Treatment Trials (NETT) Network.4 The NETT is a
multicenter network funded by the National Institute of Neu-
rologic Disorders and Stroke to conduct clinical trials related
to acute neurological illnesses. RAMPART is the first NETT
trial to use EFIC and is a double-blind, randomized clinical
trial to determine the efficacy of intramuscular midazolam
versus intravenous lorazepam for the prehospital treatment
of status epilepticus. This CC study was reviewed and
approved by the institutional review boards of the study
sites.
Our study was conducted by two NETT sites (San
Francisco and Atlanta) during CC meetings that pre-
ceded the clinical trial. RAMPART investigators at each
site identified the groups to consult with and planned
the CC activities in preparation for the trial. The exist-
ing meetings at the sites targeted condition-oriented
and geographic communities. Examples of geographic
community meetings include town hall meetings,
churches, schools, existing educational program meet-
ings for the Hispanic population of the region, and
monthly meetings for the Asian community. Individuals
or family members of individuals affected by seizure,
including individuals with a self-reported seizure disor-
der, were targeted using support of the local seizure
groups and meetings were conducted at foundations for
seizure patients and at substance abuse centers. One
site also conducted focus groups led by a trained mod-
erator. The focus group sessions were conducted by an
external contractor, and no study personnel were
involved (Table 1).
Our sample consisted of attendees over 18 years of
age who attended the CC meetings and completed
either or both of the study surveys. All adult CC partici-
pants were eligible for participation.
Survey Content and Administration
Study Instruments. Two survey instruments were
used in this study. The first instrument (CC survey) was
designed to assess the participant’s experiences with
the CC process, thoughts on how researchers might be
likely to respond to feedback from the community, and
levels of trust in physician-investigators generally (see
Data Supplement S1, available as supporting informa-
tion in the online version of this paper). The questions
regarding trust represent a previously validated four-
item scale to measure trust in medical researchers.5 The
trust scale employed Likert-scale responses ranging
from 1 = strongly disagree to 5 = strongly agree. The
Table 1
Types of CC Activities
Overview
Number of
Participants
Type of
Community
Site 1 (n = 137)
Existing Group Meeting 1 21 GC*
Existing Group Meeting 2 29 CO-C†
Existing Group Meeting 3 11 CO-C
Existing Group Meeting 4 30 CO-C
Existing Group Meeting 5 11 GC
Existing Group Meeting 6 7 CO-C
Existing Group Meeting 7 7 GC
Existing Group Meeting 8 21 CO-C
Site 2 (n = 180)
Existing Group Meeting 151 GC
Focus Group Meeting 29 CO-C/GC
Both surveys were administered at all meetings at both sites.
CC = community consultation; CO-C = condition-oriented
community; GC = geographic community.
*GC is defined as the region from which subjects are drawn
for the study
†CO-C is defined as the population with the condition that is
being studied using the clinical trial. In RAMPART, seizure/
status epilepticus is the condition of interest.
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trust score for the study was calculated based on the
methodology described by Hall et al.5; a composite trust
score by event location was calculated by adding the
mean score for each item, with reverse coding for the
one negatively phrased item.
The second instrument (EFIC survey) was a template
designed by the Clinical Coordinating Center of the
NETT Network for customization by sites for local
implementation during RAMPART CC events. The tem-
plate focused on eliciting participants’ thoughts, feel-
ings, and opinions about the RAMPART trial in general,
and conducting RAMPART under the EFIC regulations.
Specifically, level of support for the study and attitudes
toward both personal and/or family enrollment in RAM-
PART were asked (Data Supplement S2, available as
supporting information in the online version of this
paper). One site used a 5-point Likert scale and the
other site used a 4-point Likert scale in the survey sheet.
Both surveys were available in the Spanish language
for Spanish-speaking participants at the San Francisco
site (Data Supplement S3, available as supporting infor-
mation in the online version of this paper).
Existing Group Meetings. Surveys were distributed
to CC participants by members of the study team after
the conclusion of the CC meeting, which typically
included a slide presentation by a member of the RAM-
PART study team and an opportunity for discussion.
The slide presentation explained the goals and method-
ology of the clinical trial, including a careful explanation
of randomization, as well as an overview of EFIC and
its use in emergency research.
Focus Group Discussions. At one study site, four sep-
arate focus group meetings were conducted with: 1)
parents of children with seizures, 2) parents of children
without known seizures, 3) adults with seizures, and 4)
adults without known seizures. Within each group,
attempts were made to match the demographics of the
group to the local population with regard to race, socio-
economic status, and sex. Focus groups were conducted
by an independently contracted and trained moderator,
and each session was designed to last about 1 hour.6
The investigators were involved in creating the inter-
view guide and “training” the contractor. The modera-
tor led the focus group discussion after an initial
scripted presentation of study and EFIC information
(similar to the information session at the existing meet-
ings) designed jointly by the site investigators and the
contractor. Feedback was actively solicited in the focus
groups, and site investigators directly observed the ses-
sion from a private room to ensure that the feedback
was accurately understood and represented to the insti-
tutional review board. As was done at community meet-
ings, study surveys were distributed to the focus group
participants after completion of the focus group session.
Data Analysis
Raw data from the surveys were entered into a Micro-
soft Office Excel 2007 (Microsoft Corp., Redmond, WA)
spreadsheet at both sites (PG and research assistants).
The data sets from both sites were merged for analysis.
Likert scale response categories were collapsed into
agree and disagree for the 4-point scale and agree, neu-
tral, and disagree for 5-point scales. Data were analyzed
using Microsoft Office Excel 2007 and are presented as
aggregate data and percentages. Themes from the focus
group discussions were analyzed and summarized by
the contracted moderator who provided the services
and were presented as a summary report to the Atlanta
site investigators. One of the authors who was not a
RAMPART investigator (NWD) also directly observed
all four focus groups.
RESULTS
A total of 297 (94%) EFIC surveys and 189 (64%) CC
surveys were available for analysis. Demographic data
in the central database were available for 317 partici-
pants. Overall, there was a predominance of female par-
ticipants (79%) and whites (72%) in the focus group
sessions. Compared to the community demographics,
existing meetings and focus group sessions had a lower
proportion of minorities (African American and Asian
populations; Table 2).
The CC survey results (Table 3) showed that more
than 90% (n = 173) of participants agreed or strongly
agreed with the statement “I was very satisfied with this
CC meeting,” and 92% (n = 174) reported learning a lot
about research from the meeting. Although 88%
(n = 166) felt that researchers heard the community con-
cerns, only 56% (n = 106) of participants responded that
they believed researchers would make changes if
requested. It is unknown whether the responses indi-
cate that participants did not see a need for changes or
that they believed investigators would not make needed
changes.
While the surveys did not assess the nature of the con-
cerns that CC participants may have had with EFIC or
the RAMPART trial, the focus groups did provide limited
insights in this respect. The principal concerns men-
tioned among focus group participants who expressed
concerns had to do with the process of randomization,
the risks and benefits of receiving an unapproved drug,
and the loss of decision-making autonomy associated
with EFIC.
Responses by focus group participants were not sig-
nificantly different than responses from existing meet-
ing CC participants. However, the demographics of the
focus group participants were different from those of
the existing group meeting participants. Focus groups
had a predominance of females (79%) and whites (72%)
compared to the existing group participants (52%
females and 43% whites). Most focus group participants
also reported being satisfied with the meeting (83%)
and stated that researchers heard the community con-
cerns (88%). As with the other population, fewer sub-
jects (38%) felt that researchers would make changes
requested by the participants.
Responses to the questions on trust did show some
variability by event, with mean scores ranging from
12.25 to 16.48. Of note, the large event with the mean
trust score of 16.48 was an event where the participants
likely knew the presenter and were expected to have
higher trust scores. However, mean trust scores after
excluding this group did not change significantly (14.26
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vs. 14.44). In general, the totaled scores were similar
between existing meeting events and focus group
events. The average score for all CC participants (14.44)
was greater than the national sample (12.4) in which the
scale was initially validated (Table 4).
The views of the 297 participants who completed the
EFIC survey are shown in Table 5. Of the group meet-
ing participants, 88% (n = 261) supported the study
being done in their community, 70% (n = 207) said that
they would agree to participate in the study, and 68%
(n = 203) said they would agree to consent for participa-
tion of a loved one in the study. Focus group partici-
pants reported similar rates of acceptance of the trial
and enrollment under EFIC as was observed in the
existing meeting sessions (Table 5).
DISCUSSION
As part of the CC efforts for the RAMPART trial, investi-
gators at the two study sites participated in existing
Table 2
CC Meeting Participant Demographics
Demographic
Existing Meeting
(n = 288), n (%)
Focus Group
(n = 29), n (%)
San Francisco
Community, %
Atlanta
Community, %
Total
N = 317
Sex*
Male 116 (40) 6 (21) 51 50 122
Female 150 (52) 23 (79) 49 50 173
Race†
White 123 (43) 21 (72) 49 38 144
Black/African American 67 (23) 6 (21) 6 54 73
Asians 34 (12) 1 (3) 33 3 35
Native Hawaiian or Pacific Islander 6 (2) 0 (0) <1 N/A 6
American Indian or Alaska Native 11 (4) 0 (0) <1 <1 11
More than one race 8 (3) 1 (3) N/A N/A 9
Others 12 (4) 1 (3) 5 2 13
Not provided 27 (9) 0 (0) N/A N/A 27
Ethnicity†
Hispanic/Latino 20 (7) 1 (3) 15 5 21
Non-Hispanic/non-Latino 82 (28) 21 (72) 42 36 103
Not reported by participants N/A 214
CC = community consultation; N/A = not applicable.
*Data not available for 22 participants.
†Participants had indicated more than one ethnicity and the “n” exceed the total N.
Table 3
Responses to CC Survey Questions (n = 189)
Response Agree, n (%)
I was very satisfied with
this meeting
173 (92)
I learned a lot about research
at this meeting
174 (92)
I felt the researcher heard the
community concerns
166 (88)
I think the researchers will make
the changes we requested
106 (57)
I intend to help the researchers be
successful in this research
149 (79)
CC = community consultation.
Table 5
Community Views on Enrollment in the Trial Using EFIC
(n = 297)
Questions Agree, n (%)
Has the RAMPART study been
explained so that you understand
the risks and possible benefits?
273 (92)
Would you agree to participate in
this study?
207 (70)
Would you agree to consent a loved
one into this study?
203 (68)
Do you support this study being done in
your community?
261 (88)
EFIC = Exception From Informed Consent; RAMPART = Rapid
Anticonvulsant Medication Prior to Arrival Trial.
Table 4
Trust Scores by Event
CC Event
Number of
Participants (n = 189)
Mean Trust Score
(Sum of the Means)
Existing groups
Meeting 1 13 13.38
Meeting 2 22 13.50
Meeting 3 16 14.13
Meeting 4 19 14.84
Meeting 5 10 15.9
Meeting 6* 3 18
Meeting 7 6 13.71
Meeting 8 13 14.92
Meeting 9 58 16.48
Focus groups
Meeting 1 7 14.86
Meeting 2 8 12.25
Meeting 3 6 13
Meeting 4 8 14.25
CC = community consultation.
*Only three participants at this site (scores by event pre-
sented separately).
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group meetings and conducted focus group sessions.
Previous studies have reported attitudes of CC using ran-
dom-digit dialing, survey distribution at large public
gatherings, and public meetings.7–9 This study is the first,
to our knowledge, to involve multiple sites and to com-
pare attitudes of participants in focus groups and at meet-
ings convened with existing community groups. Also,
this is the first study, to our knowledge, to report on CC
participants’ level of trust in physician-investigators.
Overall, our study demonstrated a high level of sup-
port for the RAMPART trial in both communities (88%
supported the study overall). While direct comparisons
of our responses with other CC studies is limited by
some differences in the framing of the questions, similar
results (82%) were reported by a study using survey
data from a Minnesota state fair9 to understand the
community’s attitudes toward the same clinical trial.
Compared with responses regarding their general
support for the RAMPART study, CC participants
reported slightly lower support when queried about
their willingness to enroll in the study personally or to
enroll a family member. This distinction has been
reported in other studies of the general public and CC
participants.9–11 Notably, we found greater willingness
to be enrolled personally than did Biros et al.9 in ask-
ing about the same EFIC trial (70% vs. 45%). Some of
this difference may be due to the structure of the ques-
tions. Biros et al. explicitly described enrollment using
EFIC, whereas our survey only referred to willingness
to participate in the RAMPART study, without a spe-
cific reference to EFIC. An alternative explanation is
that different methods of CC may yield different
responses regarding acceptance of EFIC and enroll-
ment. In particular, the Biros et al. survey was admin-
istered to individuals who stopped at a booth at a state
fair; ours was administered after a presentation and
discussion or focus group session, contexts that may
promote more education and understanding regarding
the relevant study and that allow for some degree of
interaction and discussion regarding concerns that
may be present. These are thus very different contexts,
with one likely reflecting initial public reaction and the
other more considered opinions. The hypothesis that
greater interactiveness and discussion may lead to
higher levels of acceptance among CC participants is
also at least somewhat supported by the finding that
focus group participants had a slightly higher rate of
acceptance of enrollment than did participants in exist-
ing group meetings. These two suggestions (that
phrasing of questions and the structure of CC events
may have a significant impact on the responses of CC
participants) have been proposed before,8 but they are
of great significance to CC investigators designing, and
institutional review boards reviewing, CC plans and
results. Further work is needed to understand both the
utility of different CC methods and the expected
responses.
While detailed analysis of the focus group sessions
was not the goal of this study, the focus group sessions
did provide some insights into the nature of objections
to EFIC enrollment and this study. While the majority
of the focus group participants supported personal
enrollment as well as enrolling their loved one in the
clinical trial, reasons for reluctance to participate in the
clinical trial included concerns about the process of ran-
domization (both that emergency medical services pro-
viders would not be using their clinical judgment and
that subjects might receive an inferior treatment), con-
cerns about potential side effects and interactions of the
medications being evaluated, and concerns about being
enrolled in a trial without being asked.
Finally, our study was the first, to our knowledge, to
examine elements of trust among CC participants,
which is important for several reasons. First, we add to
the understanding of an often-cited goal of CC efforts:
fostering trust among relevant communities. Second,
our data provide knowledge on the level of trust among
CC participants. This is significant since there are some
concerns that CC processes may select individuals who
may not reflect the general population and therefore
their level of trust may not be generalizable to the rele-
vant population. In addition, it helps to determine
whether public concerns about EFIC research stem
from general mistrust regarding clinical investigation,
concerns about the absence of consent in EFIC
research, or more specific objections to elements of
proposed studies. Our results indicate that CC partici-
pants were slightly more trusting than the national
sample on which the scale was validated. This at least
suggests that CC participants in our study were not, in
general, an abnormally trusting group; CC did not
appear to select for individuals who are substantively
different from the rest of the population. However, our
study did not assess the effect of the CC session itself
on trust, and so one focus of future efforts could be to
examine this effect through the use of similar trust
scales before and after CC sessions and in the context
of different CC methods. Finally, the findings from the
focus group sessions do suggest that specific concerns
about randomization, study risks and benefits, and loss
of autonomy drove concerns about enrollment and
EFIC, rather than general sentiments of distrust. Since
the focus groups, however, were not designed to test
this hypothesis, and in-depth analysis of the focus
group sessions is not the focus of this article, these
findings must be interpreted primarily as hypothesis-
generating only.
LIMITATIONS
Studying CC participants, by definition, excludes indi-
viduals who do not participate in CC sessions. While
the sample was demographically diverse and the level
of trust seemed commensurate with the general popula-
tion, we do not know the differences between our par-
ticipants and those who declined participation in these
events. Second, while the survey responses provided a
global view of the consultants’ reaction and response to
the questions on EFIC and CC, investigators did not
have the opportunity, outside of focus group sessions,
to examine in depth the reasons for particular
responses. Finally, while the focus group sessions offset
some of the limitations of the survey design by provid-
ing a better understanding of the community’s views on
the clinical trial and EFIC, this study did not involve an
in-depth qualitative analysis of these sessions.
102 Govindarajan et al. • COMMUNITY CONSULTATION IN EMERGENCY RESEARCH
CONCLUSIONS
A majority of the participants in this study supported
the processes of community consultation and exception
from informed consent research, as well as the conduct
of the RAMPART trial in their communities. Compared
with other studies examining the attitudes of community
consultation participants or the general public regard-
ing exception from informed consent research, this
study suggests that the method of community consulta-
tion may have an effect on the level of acceptance of
exception from informed consent and personal willing-
ness to be enrolled. Community consultation partici-
pants in this study exhibited slightly higher, but similar,
levels of trust as a previously studied national sample.
However, the effect of community consultation on trust
in investigators and the effect of trust on attitudes
toward exception from informed consent studies both
warrant further evaluation
This study contributes to a growing body of literature
regarding community consultation for exception from
informed consent research and suggests important
questions to be examined in future studies in order to
best understand how to accomplish the goals of com-
munity consultation in this context. Most importantly, it
suggests that it is critical to examine the effect of differ-
ent methods of community consultation on the nature of
feedback received. Similarly, it is important to further
study the extent to which community consultation popu-
lations reflect, or do not reflect, the communities that
they are intended to represent. Community consultation
is not required by federal regulations for any other kind
of research. Understanding its goals, methods, and limi-
tations is crucial for the field of emergency research.
The authors acknowledge Amy Markowitz, JD, Clinical Transla-
tional Science Institute, University of California San Francisco, for
her editorial assistance with the manuscript.
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